In a comprehensive study published in Diabetes Care, Lipska et al. examined the relationship between glycemic control and infection-related hospitalization risk in older adults with type 2 diabetes. The findings provide nuanced insights into the balance between intensive and relaxed glycemic targets, particularly as clinical guidelines evolve to prioritize individualized care. Study Objectives and Design The... Continue Reading →
Study: Fully automated closed loop artificial pancreas
The study from colleagues in Cambridge published in the journal Nature Medicine found that a fully closed-loop insulin delivery system (CamAPS HX) improved glucose control in adults with type 2 diabetes, compared to standard insulin therapy and a masked glucose sensor (control). The proportion of time in the target glucose range was 66.3% with closed-loop... Continue Reading →
Intensive Diabetes Control Reduces Incidence of a Diabetic Foot Ulcer by 23%: DCCT @ALPSlimb #ActAgainstAmputation
Great work from Ed Boyko and coworkers who mined the Diabetes Control and Complications Trial (DCCT) for these golden data. Abstract Objective: Intensive glycemic control reduces the risk of kidney, retinal, and neurologic complications in type 1 diabetes (T1D), but whether it reduces the risk of lower-extremity complications is unknown. We examined whether former intensive versus... Continue Reading →